CME Group price target raised to $250 from $240 at Citi

Citi analyst Christopher Allen raised the firm’s price target on CME Group to $250 from $240 and keeps a Buy rating on the shares. The company’s trading activity in Q3 “remained robust,” the analyst tells investors in a research note. The firm believes the volume outlook remains solid and CME should be well positioned to benefit given its asset diversity and depth of liquidity on the platform.